Search results
Turmoil rocks New Jersey's Democratic political bosses just in time for an election
Associated Press via Yahoo News· 14 hours agoNorcross III by state Attorney General Matt Platkin caps a series of blows to influential figures in...
Oppenheimer Lowers Zentalis Pharmaceuticals (NASDAQ:ZNTL) Price Target to $25.00
ETF DAILY NEWS· 6 hours agoZentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price objective trimmed by Oppenheimer from $50.00 to $25.00 in a report issued on Tuesday morning, Benzinga reports. Wells Fargo ...
Yigal Nochomovitz Just Trimmed Price Target for Shattuck Labs, Inc. (NASDAQ:STTK)
Insider Monkey via Yahoo Finance· 11 hours agoWe recently compiled a list of the Wall Street Analysts Just Trimmed Price Targets for These 10...
Akero Therapeutics (NASDAQ:AKRO) Coverage Initiated at Wolfe Research
ETF DAILY NEWS· 6 days agoAnalysts at Wolfe Research started coverage on shares of Akero Therapeutics (NASDAQ:AKRO – Get Free Report) in a report issued on Tuesday, Benzinga reports. Evercore ISI cut their price objective ...
China wants a fleet of aircraft carriers for pride and power, and it's building it at a breakneck...
INSIDER via Yahoo News· 4 days agoAnd with the technological jumps between carrier types, that learning gap only grows. China, of...
Cantor Fitzgerald Reiterates Overweight Rating for Mereo BioPharma Group (NASDAQ:MREO)
ETF DAILY NEWS· 5 days agoMereo BioPharma Group (NASDAQ:MREO – Get Free Report)‘s stock had its “overweight” rating reiterated by stock analysts at Cantor Fitzgerald in a report issued on Wednesday, Benzinga reports.
Akero Therapeutics executive sells shares worth over $12k By Investing.com
Investing.com· 5 days agoIt's also noted that his total holdings include 561 shares acquired under the company's 2019...
Puma Biotechnology director sells $73,466 in company stock By Investing.com
Investing.com· 1 day agoPuma Biotechnology, Inc. (NASDAQ:PBYI) saw a notable transaction from one of its directors, Jay M....
Zentalis Pharmaceuticals (NASDAQ:ZNTL) PT Lowered to $20.00 at HC Wainwright
ETF DAILY NEWS· 6 hours agoZentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price objective cut by HC Wainwright from $40.00 to $20.00 in a report issued on Tuesday morning, Benzinga reports. Stifel Nicolaus ...
Turmoil rocks New Jersey's Democratic political bosses just in time for an election
San Francisco Chronicle· 14 hours agoNorcross III by state Attorney General Matt Platkin caps a series of blows to influential figures in...